CD44 and mesothelioma: However, combination treatment of ALDHhigh/CD44+ subpopulations isolated from three mesothelioma cell lines (H28, H2052 and Meso4) using the ALDH1 inhibitor, diethylaminobenzaldehyde (DEAB), induced cisplatin sensitivity in these cells and significantly reduced cell viability [45].